Actively Recruiting

Age: 18Years - 80Years
All Genders
NCT07272837

Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass

Led by University of Alberta · Updated on 2026-04-20

50

Participants Needed

1

Research Sites

106 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The aim of this study is to use advanced MRI scans to track changes in both muscle and fat in the body and heart over a 12-month period in individuals starting semaglutide. By doing so, we hope to gain a clearer understanding of how semaglutide affects muscle health and function. Our goal is to ensure the medication supports long-term well-being, particularly for people who may be at higher risk of muscle loss. This study involves (3) in-person study visits. At each visit, participants will be asked to: * Undergo magnetic resonance imaging (MRI) while resting and during exercise to take pictures of their heart, abdomen, and legs. * Complete tests to assess balance, sit-to-stand, walking speed, and handgrip strength. * Complete questionnaires related to demographics, health information, physical activity, and nutrition. * Have a blood sample collected from a vein in your arm. * Have your blood levels assessed through three finger pricks. * Complete three days of food records.

CONDITIONS

Official Title

Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass

Who Can Participate

Age: 18Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults 18-80 years of age
  • Starting semaglutide for type 2 diabetes or weight loss
  • Able to safely undergo an MRI scan (including meeting the physical requirements for MRI equipment)
Not Eligible

You will not qualify if you...

  • Current use of semaglutide for more than 2 weeks
  • Major recent heart issues or other severe health conditions
  • Concerns related to MRI use (including magnetic implants, pacemaker, severe claustrophobia)
  • Dependence on a mobility aid (unable to participate in exercise MRI)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Mazankowski Alberta Heart Institute

Edmonton, Alberta, Canada, T6G 0M9

Actively Recruiting

Loading map...

Research Team

K

Krista Jong, RD, BSc

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here